Wednesday, October 28, 2026

Scientists develop wireless implant to control diabetes without drugs


By Admin

Researchers at ETH Zurich in Switzerland have developed a wireless implant that could offer a new way to manage type 2 diabetes by converting excess sugar in the blood into a compound the body can eliminate.

The device, developed by a team led by Professor Martin Fussenegger, uses electricity to trigger a chemical reaction that breaks down glucose, raising the possibility of a drug free approach to managing the condition and obesity.

Diabetes is a chronic disease that occurs when the body cannot produce enough insulin or use the insulin it produces effectively. Insulin, a hormone made by the pancreas, helps glucose move from the bloodstream into cells, where it is used for energy.

In type 2 diabetes, the body becomes resistant to insulin or does not produce enough of it, causing blood sugar levels to rise. If poorly controlled over time, the condition can damage the heart, kidneys, eyes and nerves, and increase the risk of stroke.

Current management includes lifestyle changes such as healthy eating, regular physical activity and weight management, alongside medication when necessary. Some patients require insulin, while others use medicines that help the body regulate glucose or improve its response to insulin.

The new technology takes a different approach. Rather than relying on drugs or insulin to regulate blood sugar, it is designed to remove excess glucose through a chemical process.

According to the researchers, the implant works with a glucose sensor worn on the arm, which monitors blood sugar levels and communicates readings to a smartphone or smartwatch.

When glucose levels rise, particularly after meals, the system activates the implant. A catalyst made from graphite felt coated with tiny gold and platinum particles then converts glucose into gluconate, a compound the body can eliminate through urine.

The system automatically switches off when blood sugar returns to the target range, creating a closed loop designed to respond to changing glucose levels.

Unlike conventional diabetes treatments, the device does not rely on living cells or deliver medication. Instead, it uses electrocatalysis, a process in which electricity drives a chemical reaction.

In experiments involving diabetic mice, the researchers reported that the implant maintained blood glucose within a controlled range for six weeks. The animals also lost weight, while the team observed no signs of tissue damage during the study period.

The findings suggest that the technology could eventually offer another option for managing diabetes and obesity, conditions that are closely linked through insulin resistance and metabolic dysfunction.

The researchers see potential for the system in treating “diabesity”, a term used to describe the relationship between type 2 diabetes and obesity. By converting excess glucose into a substance that can be excreted, the device could potentially reduce the amount of sugar available for storage in the body.

However, the findings do not mean that diabetes drugs can now be abandoned. The technology has so far been tested only in mice, and further studies are needed to establish its safety, effectiveness and long term performance in humans.

It also remains unclear how the implant would perform under the varying conditions experienced by people with diabetes, or whether it could provide adequate glucose control on its own.

The study, titled “Wireless electrocatalytic closed-loop system for drug-free management of diabesity”, was published in the journal 'Science' in 2026.

Pistis Foundation’s free medical outreach records 58,394 interventions since 2019


By Admin


The Pistis Foundation’s flagship medical and surgical outreach, UBOMI, has recorded 58,394 medical interventions and reached more than 22,811 beneficiaries since 2019, providing free healthcare to people who might otherwise struggle to afford treatment.

The programme was established to address barriers to essential healthcare in underserved communities, bringing together healthcare professionals, technical partners and volunteers to make medical attention and treatment more accessible.

Its September 2026 outreach in Ibadan recorded 10,292 medical interventions and reached 3,611 beneficiaries over five days, from September 21 to 25.

The exercise offered consultations, laboratory screening, pharmacy services, eye and dental care, as well as surgical procedures. The Foundation said the results formed part of UBOMI’s broader effort to expand access to healthcare beyond Lagos and reduce the financial burden that often prevents people from seeking timely medical attention.

Meanwhile, the Lagos outreach on October 19 through 23, 2026, took place at Pistis Annex,  providing consultations, diagnostic investigations, eye and dental care, surgery and prescribed medication, subject to clinical assessment and service availability. All services were free to beneficiaries.

According to the Foundation, UBOMI’s impact extends beyond the number of procedures performed, particularly for people whose conditions have gone untreated because of the cost of healthcare. Timely access to diagnosis and treatment can improve health outcomes, independence and quality of life.

The Foundation attributed the programme’s continued delivery to collaboration among healthcare professionals, technical partners, volunteers, donors and other supporters.

Pistis Foundation is the social impact arm of The Elevation Church. Its work spans healthcare, education, child protection and empowerment through initiatives including Adopt-A-Pistis-Scholar, which supports educational opportunities for children, and Kids-Off-The-Street, which focuses on protecting and empowering vulnerable children.

Pastor Godman Akinlabi, Founder and Global Lead Pastor of The Elevation Church, founded Pistis Foundation and serves as chairman of its board.

Through UBOMI, the Foundation continues to work towards reducing financial barriers to essential healthcare and extending access to underserved communities.

Ebola: 10,060 cases, 4,887 deaths as aid response lags in DR Congo

 



By Admin


The Norwegian Refugee Council (NRC) has called for an urgent scale-up of humanitarian assistance in the Democratic Republic of the Congo (DR Congo), warning that the response to the country’s deadly Ebola outbreak is failing to keep pace with transmission.

The appeal came as confirmed cases of Bundibugyo virus disease reached 10,060, with 4,887 deaths recorded as of October 25, making the outbreak the largest and deadliest in DR Congo’s history.

The outbreak has affected eight provinces, with eastern DR Congo bearing the heaviest burden. Recent cases reported in Kenya and Nigeria have heightened concerns about further regional spread.

Silvia Beccacece, NRC emergency team leader, said the scale of the outbreak was far beyond what the current humanitarian response could adequately address, leaving communities struggling to cope with the disease alongside years of violence, displacement and inadequate essential services.

“As I move around Ituri I’m seeing just how hard the disease is hitting communities, and I am struck by how much more needs to be done to bring this outbreak under control. The fact remains that this response is in no way proportionate to the vast scale of the outbreak,” Beccacece said.

She noted that many families in Ituri had endured years of extreme violence, forced displacement and poor access to essential services before Ebola struck, further weakening their ability to withstand the outbreak.

Beccacece warned that the milestone of 10,000 confirmed cases should prompt urgent action from governments, donors and humanitarian partners to expand support and help communities contain transmission.

“10,000 confirmed cases must be a wake-up call that this response is not getting ahead of the outbreak, and is not supporting communities with what they need to bring transmission under control,” she said.

“The warning signs are here for all to see: now it depends on whether leaders will take notice and take the required action.”

The NRC called for sustained, coordinated intervention involving health authorities, humanitarian organisations, community groups and international partners, stressing that affected communities must remain central to the response and that interventions should respect local customs and traditions.

The organisation, which has operated in DR Congo for more than two decades, is supporting Ebola response activities in 19 affected health zones, including targeted operations in Ituri, while continuing humanitarian assistance in high-risk and displacement-affected areas.

Its interventions include infection prevention and control, water, sanitation and hygiene services, and community engagement to improve awareness and support safer practices. The organisation is also working with schools to help them operate safely during the outbreak.

The NRC urged donors and international partners to increase funding for humanitarian operations, particularly in communities facing both Ebola transmission and displacement.

DR Congo has endured a prolonged humanitarian crisis, with conflict and population displacement compounding weaknesses in essential services. The country has featured on the NRC’s list of the world’s most neglected displacement crises for 10 consecutive years.

The latest appeal underscores growing concern that the Ebola response must expand beyond disease control to address the conditions that leave communities vulnerable, including disrupted access to healthcare, safe water, sanitation and other basic services.

ACADMEDS to induct 13 researchers, spotlight genomics in non-communicable disease care Oct 30

...Prof Azeez Butali to deliver keynote at October 30 conference as Chinenye leads memorial lecture




By Admin


The Academy of Medical Sciences of Nigeria will induct 13 researchers and convene experts on the clinical applications of genetics and genomics in non-communicable disease management at its annual scientific conference in Lagos on October 30.

The conference, scheduled for the Marriott Lagos Hotel, Ikeja, will focus on the theme, “The Genetics and Genomics of Non-Communicable Diseases: Integrating Science into Clinical Care.”

Announcing the programme at a pre-conference press briefing in Lagos, the Academy’s President Emeritus, Professor Osato Frank Giwa-Osagie, said the event would bring together experts to examine how advances in genetics and genomics could improve disease diagnosis, prevention and treatment.

The keynote address, titled “The Joy of the Human Genome: Discovery to Clinical Care,” will be delivered by Professor Azeez Butali of the University of Iowa College of Dentistry, United States. Butali is a professor of craniofacial genetics and diagnostic sciences and directs the African Craniofacial Anomalies Network. He is also a member of the Smile Train Research and Innovations Advisory Council.

The programme will feature eight distinguished speakers and poster presentations, providing a platform for researchers to share findings and discuss the translation of scientific discoveries into clinical practice.

The 13 researchers to be inducted represent diverse fields of medical science. They are Dr Abiola A. Adeniyi (dental public health); Professors Sunday O. Akintoye (oral medicine), Emmanuel O. Balogun (molecular biology), Rasheed A. Balogun (nephrology), Ene I. Ette (clinical pharmacology), and  Okechukwu S. Ogah (cardiology).

Others are Omonike O. Ogbole (pharmacognosy), Anthony O. Okorodudu (pathology), Olusola O. Olawoye (ophthalmology), Adebola E. Orimadegun (paediatrics), Bamidele V. Owoyele (physiology), Wellington A. Oyibo (medical parasitology) and Musa T. Yakubu (biochemical toxicology).

The conference will also feature the second Augustine Ohwovoriole Memorial Lecture, to be delivered by Professor Sunday Chinenye, a professor of endocrinology at the University of Port Harcourt. The lecture honours the late Professor Augustine Ohwovoriole, an endocrinologist and founding member of the Academy’s Board of Trustees.

A major highlight will be the presentation of the Academy’s inaugural Gold Medal Award to Professor Okechukwu Samuel Ogah, a professor of medicine at the University of Ibadan and consultant cardiologist at University College Hospital, Ibadan. The award carries a cash prize of ₦10 million.

Ogah, a former president of the Nigerian Cardiac Society, has published more than 120 peer-reviewed papers. His research focuses on hypertension, heart failure, cardiomyopathies and cardiovascular epidemiology in Africa.

The conference will also mark the transition to new leadership under Professor Joseph Eberendu Ahaneku, a chemical pathologist and former vice-chancellor of Nnamdi Azikiwe University, who served from 2014 to 2019.

Established in June 2019, the Academy is an independent, non-profit body that provides evidence-based advice on medical care, public health, medical education and research.

It has also called on government to draw more extensively on the expertise of Nigerian medical scientists in shaping health policy and strengthening disease surveillance, including responses to public health threats such as Ebola, Lassa fever and diphtheria.

AMR: Global experts worry over rising antibiotic use, seek urgent action to avert superbug crisis

By Sola Charles  With antibiotic use in livestock projected to rise by nearly 30 per cent by 2040, global health experts have wa...